Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02717702 · ClinicalTrials.gov registry record
Stress-Delta Biomarkers for Acute Coronary Syndrome Risk Stratification
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 125
- Enrollment target
NCT02717702 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 125 participants.
The verdict
NCT02717702 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
Acute Coronary Syndrome (ACS) is a serious heart condition that is a leading cause of death in America. Cardiac stress testing is currently the best test to non-invasively identify which patients might be having ACS and may need more invasive testing such as a cardiac catheterization (placing a tube in the heart) for coronary angiogram (invasive mapping of the blood vessels of the heart). However, stress tests require imaging by highly trained specialists and even then may not correctly categorize a small minority of patients being evaluated for ACS. Advances in blood tests may now allow detection of the very early stages of heart blood vessel blockage via a simple blood test. The investigators seek to determine whether these blood tests can help to better identify patients with ACS. The study will also store any extra blood sample that may be left over for future use.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2016-08-10 |
| Est. Completion | 2019-06-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02717702
The ClinicalTrials.gov registry entry for NCT02717702 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02717702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02717702 about?
NCT02717702 is a clinical study titled "Stress-Delta Biomarkers for Acute Coronary Syndrome Risk Stratification". Acute Coronary Syndrome (ACS) is a serious heart condition that is a leading cause of death in America. Cardiac stress testing is currently the best test to non-invasively identify which patients might be having ACS and may need more invasive testing such as a cardiac catheterization (placing a tube...
What is the current status of trial NCT02717702?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2016-08-10. Estimated completion is 2019-06-11.
Who is sponsoring clinical trial NCT02717702?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.